Epidermolysis bullosa acquisita localized to the face.
A 39-year-old woman had a three-year history of recurrent bullous eruption localized to her left cheek. The diagnosis of epidermolysis bullosa acquisita was confirmed by means of direct immunofluorescence and direct immunoelectron microscopic studies performed on the perilesional salt-split skin. Topical corticosteroid treatment reduced pruritus and bullae formation. This case of localized epidermolysis bullosa acquisita on the face is reminiscent of Brunsting-Perry cicatricial pemphigoid. We also review the previously reported cases of localized epidermolysis bullosa acquisita.
Choi
G S
GS
Department of Dermatology, Yonsei University College of Medicine, Yongdong Severance Hospital, Seoul, Korea.
Lee
E S
ES
Kim
S C
SC
Lee
S
S
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001768:Blister / Q000188:drug therapy; D003176:Complement C3 / Q000032:analysis; D003937:Diagnosis, Differential; D004804:Eosinophils / Q000473:pathology; D016107:Epidermolysis Bullosa Acquisita / Q000188:drug therapy / Q000473:pathology*; D005148:Facial Dermatoses / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D005500:Follow-Up Studies; D005938:Glucocorticoids; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D016253:Microscopy, Immunoelectron; D009504:Neutrophils / Q000473:pathology; D010390:Pemphigoid, Benign Mucous Membrane / Q000175:diagnosis; D011537:Pruritus / Q000188:drug therapy; D012008:Recurrence
D000893:Anti-Inflammatory Agents; D003176:Complement C3; D005938:Glucocorticoids; D007074:Immunoglobulin G